AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Gliclavac-M Tablet

Prescription Icon
Prescription Required

Marketer

Prevego Healthcare & Research Private Limited

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Gliclavac-M Tablet

Diabetace-Duo tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. They regulate blood glucose. Take Diabetace-Duo with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication even if feeling well or with controlled blood sugar; abrupt cessation can lead to elevated glucose, risking kidney complications, vision loss, neuropathy, and limb damage. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar), constipation, and nausea. Learn to recognize hypoglycemia symptoms—sweating, dizziness, headache, tremors—and how to manage them. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use Diabetace-Duo if you have type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor of any history of heart disease before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should consult their physician. Regular blood glucose monitoring is essential, and your doctor may order blood tests to check blood cell counts and liver function.

Uses of Gliclavac-M Tablet

Diabetes mellitus type 2

Major Benefits of Gliclavac-M Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Gliclavac-M Tablet with a meal.

Common Side effects of Gliclavac-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclavac-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Gliclavac-M should be administered with food.

How Gliclavac-M Tablet works:

Gliclazide and metformin are combined in Gliclavac-M tablets to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliclavac-M Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliclavac-M tablets during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Gliclavac-M tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliclavac-M tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Gliclavac-M tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliclavac-M Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate hepatic dysfunction, a low initial Gliclavac-M Tablet dose is typically recommended; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Gliclavac-M Tablet :

Should you forget a Gliclavac-M Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Gliclavac-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Gliclavac-M Tablet

Gliclavac-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Gliclavac-M is not suitable for type 1 diabetes.
Gliclavac-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclavac-M Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclavac-M Tablet can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Gliclavac-M Tablet and seek immediate medical attention.
Prolonged Gliclavac-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Gliclavac-M Tablets are contraindicated in patients allergic to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gliclavac-M Tablet with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Gliclavac-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Gliclavac-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclavac-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclavac-M Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Gliclavac-M and seek immediate medical attention.
Prolonged Gliclavac-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake is recommended annually, according to some researchers.
Gliclavac-M Tablets are contraindicated in patients allergic to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gliclavac-M Tablet and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Gliclavac-M Tablet
89
MRP 109
18% off